Search results

Search for "virus-like particles" in Full Text gives 4 result(s) in Beilstein Journal of Nanotechnology.

Alcohol-perturbed self-assembly of the tobacco mosaic virus coat protein

  • Ismael Abu-Baker and
  • Amy Szuchmacher Blum

Beilstein J. Nanotechnol. 2022, 13, 355–362, doi:10.3762/bjnano.13.30

Graphical Abstract
  • ]. Biological scaffolds can be programmed through predictable chemical interactions, such as DNA base pairing, disulfide bond formation, and metal coordination, to form complex, well-defined nanostructures [5][6]. Viruses and virus-like particles (VLPs) possess many advantageous properties for biotemplating
  • to work with virus-like particles composed of the viral capsid proteins without the viral genome. One of the most extensively studied viral templates is the tobacco mosaic virus [15]. The native virus forms helical rod-shaped particles composed of ca. 2130 copies of the coat protein. The particles
  • assembly of macromolecular components is well-established with many other systems, including lipids, synthetic polymers, and peptides, but has been the subject of few studies with virus-like particles [28][29][30][31]. Lauffer and Shalaby reported that glycine-based molecules promoted the polymerization of
PDF
Album
Supp Info
Full Research Paper
Published 01 Apr 2022

A review on the green and sustainable synthesis of silver nanoparticles and one-dimensional silver nanostructures

  • Sina Kaabipour and
  • Shohreh Hemmati

Beilstein J. Nanotechnol. 2021, 12, 102–136, doi:10.3762/bjnano.12.9

Graphical Abstract
  • surface. We have recently reviewed engineered TMV and its viruslikeparticles (VLPs) for synthesis of biotemplated nanomaterials. We also discussed the recent advances on novel barely stripe mosaic virus (BSMV) and its VLP as a novel template for metal nanoparticle synthesis [273][274]. 3.4 Algae
PDF
Album
Review
Published 25 Jan 2021

Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes

  • Alfredo Nuñez-Rivera,
  • Pierrick G. J. Fournier,
  • Danna L. Arellano,
  • Ana G. Rodriguez-Hernandez,
  • Rafael Vazquez-Duhalt and
  • Ruben D. Cadena-Nava

Beilstein J. Nanotechnol. 2020, 11, 372–382, doi:10.3762/bjnano.11.28

Graphical Abstract
  • effects on tumor cells in vitro. However, only BMV did not activate macrophages in vitro. This suggests that BMV is less immunogenic and may be a potential carrier for therapy delivery in tumor cells. Furthermore, BMV virus-like particles (VLPs) were efficiently loaded with small interfering RNA (siRNA
  • chlorotic mottle virus (CCMV); nanocarriers; plant virus-like particles (VLPs); siRNA delivery; small interfering RNA (siRNA); Introduction Despite many efforts taken, the efficient and specific delivery of therapeutic molecules to tumor cells is still a unsolved challenge. Cancer therapies are often
  • ]. The accumulation of nanoparticles in tumors, either passively or directed, is extensively documented [14]. Thus, there are multiple efforts to design nanoparticles that function as nanovehicles, mainly composed of liposomes, synthetic polymers, dendrimers, and virus-like particles (VLPs) [13][15
PDF
Album
Supp Info
Full Research Paper
Published 20 Feb 2020

Novel roles for well-known players: from tobacco mosaic virus pests to enzymatically active assemblies

  • Claudia Koch,
  • Fabian J. Eber,
  • Carlos Azucena,
  • Alexander Förste,
  • Stefan Walheim,
  • Thomas Schimmel,
  • Alexander M. Bittner,
  • Holger Jeske,
  • Hartmut Gliemann,
  • Sabine Eiben,
  • Fania C. Geiger and
  • Christina Wege

Beilstein J. Nanotechnol. 2016, 7, 613–629, doi:10.3762/bjnano.7.54

Graphical Abstract
  • ; enzyme biosensor; nanotechnology; tobacco mosaic virus; virus-like particles; Introduction In the early years of virology, viruses were primarily regarded as small infective agents sometimes causing fatal diseases. Today, viruses and virus-like particles (VLPs) are seen in a different light by a
  • possibilities for viruses are as versatile as the composition of the interdisciplinary teams working on them. In the following, we report on trends in the gradually changing field of research on virus and virus-like particles, with special focus on the well-known TMV nanosticks and their use as nanostructured
  • plant-made effector proteins, pharmaceuticals and virus-like particles especially for vaccination purposes are regarded economically valuable, attractive alternatives to conventionally produced compounds. This is attested by a rapidly growing number of present reports and companies specializing in this
PDF
Album
Review
Published 25 Apr 2016
Other Beilstein-Institut Open Science Activities